Municipal Employees Retirement System of Michigan increased its stake in shares of Integra LifeSciences Holdings Corporation (NASDAQ:IART) by 1.6% during the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 6,440 shares of the company’s stock after buying an additional 100 shares during the period. Municipal Employees Retirement System of Michigan’s holdings in Integra LifeSciences Holdings Corporation were worth $532,000 at the end of the most recent reporting period.

Other institutional investors also recently made changes to their positions in the company. FMR LLC raised its position in shares of Integra LifeSciences Holdings Corporation by 3.5% in the second quarter. FMR LLC now owns 4,883,849 shares of the company’s stock worth $389,633,000 after buying an additional 163,600 shares during the period. Vanguard Group Inc. raised its position in shares of Integra LifeSciences Holdings Corporation by 5.9% in the second quarter. Vanguard Group Inc. now owns 2,408,001 shares of the company’s stock worth $192,111,000 after buying an additional 133,775 shares during the period. BlackRock Fund Advisors raised its position in shares of Integra LifeSciences Holdings Corporation by 8.6% in the third quarter. BlackRock Fund Advisors now owns 2,165,730 shares of the company’s stock worth $178,781,000 after buying an additional 171,412 shares during the period. Champlain Investment Partners LLC raised its position in shares of Integra LifeSciences Holdings Corporation by 9.6% in the second quarter. Champlain Investment Partners LLC now owns 1,643,325 shares of the company’s stock worth $131,104,000 after buying an additional 143,925 shares during the period. Finally, Victory Capital Management Inc. acquired a new position in shares of Integra LifeSciences Holdings Corporation during the third quarter worth about $63,680,000. Institutional investors own 88.21% of the company’s stock.

Institutional Ownership by Quarter for Integra LifeSciences Holdings Corporation (NASDAQ:IART)

Integra LifeSciences Holdings Corporation (NASDAQ:IART) traded up 0.31% on Friday, hitting $42.49. The stock had a trading volume of 1,213,070 shares. Integra LifeSciences Holdings Corporation has a one year low of $27.38 and a one year high of $45.50. The stock has a 50-day moving average of $78.65 and a 200-day moving average of $81.39. The company has a market cap of $3.18 billion, a PE ratio of 55.33 and a beta of 0.75.

Integra LifeSciences Holdings Corporation (NASDAQ:IART) last issued its quarterly earnings data on Thursday, October 27th. The company reported $0.93 EPS for the quarter, topping the Zacks’ consensus estimate of $0.89 by $0.04. The firm earned $250.30 million during the quarter, compared to the consensus estimate of $249.30 million. Integra LifeSciences Holdings Corporation had a return on equity of 16.11% and a net margin of 6.09%. The firm’s revenue was up 10.6% on a year-over-year basis. During the same period in the prior year, the business earned $0.75 EPS. Equities analysts expect that Integra LifeSciences Holdings Corporation will post $1.75 earnings per share for the current fiscal year.

WARNING: This piece of content was published by Watch List News and is the sole property of of Watch List News. If you are viewing this piece of content on another site, it was copied illegally and reposted in violation of U.S. and international copyright law. The original version of this piece of content can be read at http://www.watchlistnews.com/integra-lifesciences-holdings-corporation-iart-position-boosted-by-municipal-employees-retirement-system-of-michigan/1060899.html.

A number of brokerages have recently issued reports on IART. Royal Bank Of Canada lowered their target price on shares of Integra LifeSciences Holdings Corporation from $85.00 to $46.00 and set a “sector perform” rating on the stock in a research report on Friday. RBC Capital Markets lowered their price objective on shares of Integra LifeSciences Holdings Corporation from $85.00 to $46.00 and set a “sector perform” rating on the stock in a research report on Friday. Barclays PLC reiterated an “equal weight” rating and issued a $42.00 price objective (down from $84.00) on shares of Integra LifeSciences Holdings Corporation in a research report on Friday. Zacks Investment Research lowered shares of Integra LifeSciences Holdings Corporation from a “buy” rating to a “hold” rating in a research report on Friday, January 6th. Finally, JMP Securities upgraded shares of Integra LifeSciences Holdings Corporation from a “market perform” rating to an “outperform” rating and set a $50.00 price objective on the stock in a research report on Friday, January 6th. Four analysts have rated the stock with a hold rating, seven have issued a buy rating and one has issued a strong buy rating to the stock. The company has an average rating of “Buy” and a consensus target price of $47.15.

In related news, CEO Peter J. Arduini sold 24,009 shares of the company’s stock in a transaction on Tuesday, November 8th. The stock was sold at an average price of $79.51, for a total transaction of $1,908,955.59. Following the completion of the transaction, the chief executive officer now directly owns 25,593 shares in the company, valued at approximately $2,034,899.43. The sale was disclosed in a document filed with the SEC, which is available through this link. Corporate insiders own 21.40% of the company’s stock.

About Integra LifeSciences Holdings Corporation

Integra LifeSciences Holdings Corporation is a medical technology company. The Company focuses on the development, manufacturing and marketing of surgical implants and medical instruments. Its products are used in neurosurgery, extremity reconstruction, orthopedics and general surgery. Its segments include Specialty Surgical Solutions, which offers products, including specialty surgical instrumentation for a range of specialties.

5 Day Chart for NASDAQ:IART

Want to see what other hedge funds are holding IART? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Integra LifeSciences Holdings Corporation (NASDAQ:IART).

Receive News & Ratings for Integra LifeSciences Holdings Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Integra LifeSciences Holdings Corporation and related companies with Analyst Ratings Network's FREE daily email newsletter.